14 octubre 2015
Primary care providers are put in a difficult position when screening their male patients for prostate cancer — some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients. Now a new perspective piece offers some guidance on when to screen patients and how to involve them in decisions about screening and treatment.
http://www.sciencedaily.com/releases/2015/10/151014132404.htm
